Literature DB >> 28249837

U-shaped relationship between serum uric acid levels and intrarenal hemodynamic parameters in healthy subjects.

Hideki Uedono1, Akihiro Tsuda2, Eiji Ishimura1, Shinya Nakatani1, Masafumi Kurajoh1, Katsuhito Mori1, Junji Uchida3, Masanori Emoto1, Tatsuya Nakatani3, Masaaki Inaba1.   

Abstract

Hyperuricemia has been reported to affect renal hemodynamics. In a recent study, both low and high levels of serum uric acid (SUA) were found to be associated with loss of kidney function. The goal of this study was to evaluate the relationship between SUA levels and intrarenal hemodynamic parameters in healthy subjects, using plasma clearance of para-aminohippurate (CPAH) and inulin (Cin). Renal and glomerular hemodynamics were evaluated by simultaneous measurements of CPAH and Cin in 48 healthy subjects (54.6 ± 13.4 yr). Intrarenal hemodynamic parameters, including efferent and afferent (Ra) arteriolar resistance, were calculated using Gómez's formulas. Relationships of SUA levels with these intrarenal hemodynamic parameters were examined. In quadratic regression analysis, SUA levels had a significant inverse U-shaped relationship with Cin (P < 0.0001, R2 = 0.350) and CPAH (P = 0.0093, R2 = 0.188) and a U-shaped relationship with Ra (P = 0.0011, R2 = 0.262). In multiple regression analysis with normal (3.5-6.0 mg/dl) and mildly low or high (<3.5 or >6.0 mg/dl) SUA levels entered as dummy variables of zero and one, respectively, mildly low or high SUA levels were significantly and independently associated with Ra (β = 0.230, P = 0.0403) after adjustment for several factors (R2 = 0.597, P < 0.0001). Both mild hyperuricemia and mild hypouricemia are significantly associated with increased Ra, although weakly. The increase in Ra in subjects with mild hyperuricemia or hypouricemia may be related to renal hemodynamic abnormalities, possibly leading to a decline in renal function.
Copyright © 2017 the American Physiological Society.

Entities:  

Keywords:  inulin clearance; para-aminohippurate clearance; renal hemodynamics

Mesh:

Substances:

Year:  2017        PMID: 28249837     DOI: 10.1152/ajprenal.00645.2016

Source DB:  PubMed          Journal:  Am J Physiol Renal Physiol        ISSN: 1522-1466


  10 in total

1.  Elevated Serum Uric Acid Is Associated With Greater Risk for Hypertension and Diabetic Kidney Diseases in Obese Adolescents With Type 2 Diabetes: An Observational Analysis From the Treatment Options for Type 2 Diabetes in Adolescents and Youth (TODAY) Study.

Authors:  Petter Bjornstad; Lori Laffel; Jane Lynch; Laure El Ghormli; Ruth S Weinstock; Sherida E Tollefsen; Kristen J Nadeau
Journal:  Diabetes Care       Date:  2019-04-09       Impact factor: 19.112

2.  Association between uric acid, renal haemodynamics and arterial stiffness over the natural history of type 1 diabetes.

Authors:  Yuliya Lytvyn; Petter Bjornstad; Julie A Lovshin; Sunita K Singh; Genevieve Boulet; Mohammed A Farooqi; Vesta Lai; Josephine Tse; Leslie Cham; Leif E Lovblom; Alanna Weisman; Hillary A Keenan; Michael H Brent; Narinder Paul; Vera Bril; Andrew Advani; Etienne Sochett; Bruce A Perkins; David Z I Cherney
Journal:  Diabetes Obes Metab       Date:  2019-03-28       Impact factor: 6.577

3.  Serum Uric Acid Levels and Nephrosclerosis in a Population-Based Autopsy Study: The Hisayama Study.

Authors:  Kenji Maki; Jun Hata; Satoko Sakata; Emi Oishi; Yoshihiko Furuta; Toshiaki Nakano; Yoshinao Oda; Takanari Kitazono; Toshiharu Ninomiya
Journal:  Am J Nephrol       Date:  2022-02-01       Impact factor: 3.754

4.  Association of hyperuricemia with disease severity in chronic hepatitis C patients.

Authors:  Tyng-Yuan Jang; Ming-Lun Yeh; Ching-I Huang; Zu-Yau Lin; Shinn-Cherng Chen; Meng-Hsuan Hsieh; Chia-Yen Dai; Jee-Fu Huang; Chung-Feng Huang; Wan-Long Chuang; Ming-Lung Yu
Journal:  PLoS One       Date:  2018-11-05       Impact factor: 3.240

5.  Higher serum uric acid level is inversely associated with renal function assessed by cystatin C in a Japanese general population without chronic kidney disease: the KOBE study.

Authors:  Sachimi Kubo; Yoko Nishida; Yoshimi Kubota; Aya Higashiyama; Daisuke Sugiyama; Takumi Hirata; Naomi Miyamatsu; Ayumi Tanabe; Aya Hirata; Yukako Tatsumi; Aya Kadota; Kazuyo Kuwabara; Tomofumi Nishikawa; Yoshihiro Miyamoto; Tomonori Okamura
Journal:  BMC Nephrol       Date:  2019-04-02       Impact factor: 2.388

6.  Plasma uric acid and renal haemodynamics in type 2 diabetes patients.

Authors:  Danii Ls Suijk; Mark M Smits; Marcel Ha Muskiet; Lennart Tonneijck; Mark Hh Kramer; Jaap A Joles; Daniël H van Raalte
Journal:  Nephrology (Carlton)       Date:  2019-09-12       Impact factor: 2.506

7.  Effect of chronic kidney disease on the association between hyperuricemia and new-onset hypertension in the general Japanese population: ISSA-CKD study.

Authors:  Miki Kawazoe; Shunsuke Funakoshi; Shintaro Ishida; Chikara Yoshimura; Atsushi Satoh; Toshiki Maeda; Masayoshi Tsuji; Soichiro Yokota; Kazuhiro Tada; Koji Takahashi; Kenji Ito; Tetsuhiko Yasuno; Hideyuki Fujii; Shota Okutsu; Shigeaki Mukobara; Daiji Kawanami; Shigeki Nabeshima; Seiji Kondo; Kosuke Masutani; Hisatomi Arima
Journal:  J Clin Hypertens (Greenwich)       Date:  2021-11-21       Impact factor: 3.738

8.  Association between polymorphism at IGF-1 rs35767 gene locus and long-term decline in renal function: a Japanese retrospective longitudinal cohort study.

Authors:  Kosuke Honda; Satoru Kuriyama; Kimiyoshi Ichida; Tomoko Nakano; Naoki Sugano; Takashi Yokoo
Journal:  BMC Nephrol       Date:  2021-06-02       Impact factor: 2.388

9.  Xanthine Oxidase Inhibition by Febuxostat in Macrophages Suppresses Angiotensin II-Induced Aortic Fibrosis.

Authors:  Masateru Kondo; Masaki Imanishi; Keijo Fukushima; Raiki Ikuto; Yoichi Murai; Yuya Horinouchi; Yuki Izawa-Ishizawa; Mitsuhiro Goda; Yoshito Zamami; Kenshi Takechi; Masayuki Chuma; Yasumasa Ikeda; Hiromichi Fujino; Koichiro Tsuchiya; Keisuke Ishizawa
Journal:  Am J Hypertens       Date:  2019-02-12       Impact factor: 2.689

10.  Severe Hypouricemia Impairs Endothelium-Dependent Vasodilatation and Reduces Blood Pressure in Healthy Young Men: A Randomized, Placebo-Controlled, and Crossover Study.

Authors:  Benjamin De Becker; Catherine Coremans; Martin Chaumont; Cédric Delporte; Pierre Van Antwerpen; Thierry Franck; Alexandre Rousseau; Karim Zouaoui Boudjeltia; Pierre Cullus; Philippe van de Borne
Journal:  J Am Heart Assoc       Date:  2019-11-22       Impact factor: 5.501

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.